- Home
- WOOF vs IMNM Comparison
WOOF vs IMNM Comparison
Compare WOOF & IMNM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WOOF
- IMNM
- Stock Information
- Founded
- WOOF 1965
- IMNM 2006
- Country
- WOOF United States
- IMNM United States
- Employees
- WOOF N/A
- IMNM N/A
- Industry
- WOOF Other Specialty Stores
- IMNM Medicinal Chemicals and Botanical Products
- Sector
- WOOF Consumer Discretionary
- IMNM Health Care
- Exchange
- WOOF Nasdaq
- IMNM Nasdaq
- Market Cap
- WOOF 1.0B
- IMNM 806.1M
- IPO Year
- WOOF 2021
- IMNM 2020
- Fundamental
- Price
- WOOF $2.96
- IMNM $6.99
- Analyst Decision
- WOOF Buy
- IMNM Strong Buy
- Analyst Count
- WOOF 10
- IMNM 5
- Target Price
- WOOF $3.85
- IMNM $26.60
- AVG Volume (30 Days)
- WOOF 5.3M
- IMNM 1.0M
- Earning Date
- WOOF 03-26-2025
- IMNM 03-19-2025
- Dividend Yield
- WOOF N/A
- IMNM N/A
- EPS Growth
- WOOF N/A
- IMNM N/A
- EPS
- WOOF N/A
- IMNM N/A
- Revenue
- WOOF $6,116,462,000.00
- IMNM $9,041,000.00
- Revenue This Year
- WOOF $5.01
- IMNM N/A
- Revenue Next Year
- WOOF $2.13
- IMNM $476.80
- P/E Ratio
- WOOF N/A
- IMNM N/A
- Revenue Growth
- WOOF N/A
- IMNM N/A
- 52 Week Low
- WOOF $1.41
- IMNM $6.90
- 52 Week High
- WOOF $6.29
- IMNM $24.87
- Technical
- Relative Strength Index (RSI)
- WOOF 57.93
- IMNM 31.33
- Support Level
- WOOF $2.39
- IMNM $6.94
- Resistance Level
- WOOF $3.42
- IMNM $7.68
- Average True Range (ATR)
- WOOF 0.21
- IMNM 0.57
- MACD
- WOOF 0.10
- IMNM -0.14
- Stochastic Oscillator
- WOOF 59.65
- IMNM 3.47
About WOOF Petco Health and Wellness Company Inc.
Petco Health and Wellness Co Inc is a pet health and wellness company focused on improving the lives of pets, pet parents, and its partners with approximately 1,423 pet care centers offering pet care products such as puppy food, treats, nutrition, and supplies through retail outlets and online platforms. The company generates revenue from the sale of products and services such as dog and cat food, supplies, and companion animals, among others.
About IMNM Immunome Inc.
Immunome Inc is a biopharmaceutical company. It is engaged in utilizing a proprietary human memory B cell platform to discover and develop first-in-class antibody therapeutics designed to change the way diseases are currently being treated. The objective of the company is to establish a broad pipeline of preclinical and clinical assets which itcan efficiently develop through successive value inflection points. The company's primary focus areas are oncology and infectious disease, including COVID-19. It operates in the U.S. Its current pipelines comprise IM-1021, a fibroblast activation protein (FAP) and and IM-4320.